0001209191-23-054352.txt : 20231103 0001209191-23-054352.hdr.sgml : 20231103 20231103165425 ACCESSION NUMBER: 0001209191-23-054352 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231101 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nabulsi Azmi CENTRAL INDEX KEY: 0001791412 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39094 FILM NUMBER: 231377127 MAIL ADDRESS: STREET 1: C/O PHATHOM PHARMACEUTICALS, INC. STREET 2: 2150 E. LAKE COOK ROAD, SUITE 800 CITY: BUFFALO GROVE STATE: IL ZIP: 60089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001783183 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824151574 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE, STREET 2: SUITE 102 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (877) 742-8466 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE, STREET 2: SUITE 102 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-01 0 0001783183 Phathom Pharmaceuticals, Inc. PHAT 0001791412 Nabulsi Azmi C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102 FLORHAM PAK NJ 07932 0 1 0 0 Chief Operating Officer 0 Common Stock 2023-11-01 4 A 0 32500 0.00 A 242067 D Common Stock 3578.93 I By 401(k) Common Stock 785700 I by Trust Represents shares earned with respect to performance stock unit awards granted on July 1, 2020 and January 19, 2023 that contained a performance-vesting requirement that was satisfied on November 1, 2023. /s/ Larry Miller, Attorney-in-Fact for Azmi Nabulsi 2023-11-03